{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:44:16Z","timestamp":1776674656797,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01016-w","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:53:25Z","timestamp":1773284005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response assessment in rectal cancer undergoing total neoadjuvant therapy: decision tree analysis integrating contrast enhanced T1-weighted MRI"],"prefix":"10.1186","volume":"26","author":[{"given":"An-Hsin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Yi-Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Fu","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gigin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Chieh","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"17","key":"1016_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"9666","key":"1016_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811\u201320.","journal-title":"Lancet"},{"issue":"16","key":"1016_CR3","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926\u201333.","journal-title":"J Clin Oncol"},{"key":"1016_CR4","doi-asserted-by":"crossref","unstructured":"Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4(6):e180071.","DOI":"10.1001\/jamaoncol.2018.0071"},{"issue":"34","key":"1016_CR5","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1200\/JCO.19.00308","volume":"37","author":"E Fokas","year":"2019","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Randomized phase II trial of chemoradiotherapy plus induction or Consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Educ Chang Clin Oncol. 2019;37(34):3212\u201322.","journal-title":"J Educ Chang Clin Oncol"},{"issue":"1","key":"1016_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. The Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"The Lancet Oncol"},{"key":"1016_CR7","doi-asserted-by":"crossref","unstructured":"Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, et al. Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Oncologist. 2021;26(9):e1555\u201366.","DOI":"10.1002\/onco.13824"},{"key":"1016_CR8","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22\u201340.","DOI":"10.1093\/annonc\/mdx224"},{"issue":"2","key":"1016_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1148\/rg.2019180075","volume":"39","author":"KR Kalisz","year":"2019","unstructured":"Kalisz KR, Enzerra MD, Paspulati RM. MRI evaluation of the response of rectal cancer to neoadjuvant chemoradiation therapy. Radiographics. 2019;39(2):538\u201356.","journal-title":"Radiographics"},{"issue":"2","key":"1016_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1148\/rg.2019180114","volume":"39","author":"N Horvat","year":"2019","unstructured":"Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39(2):367\u201387.","journal-title":"Radiographics"},{"issue":"7","key":"1016_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3348\/kjr.2018.0611","volume":"20","author":"N Seo","year":"2019","unstructured":"Seo N, Kim H, Cho MS, Lim JS. Response assessment with MRI after chemoradiotherapy in rectal cancer: current evidences. Korean J Radiol. 2019;20(7):1003\u201318.","journal-title":"Korean J Radiol"},{"issue":"28","key":"1016_CR12","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1200\/JCO.2011.34.9068","volume":"29","author":"UB Patel","year":"2011","unstructured":"Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(28):3753\u201360.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1016_CR13","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1245\/s10434-011-1607-5","volume":"18","author":"DM Lambregts","year":"2011","unstructured":"Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18(8):2224\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1016_CR14","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1007\/s00330-013-2956-1","volume":"23","author":"S Sassen","year":"2013","unstructured":"Sassen S, de Booij M, Sosef M, Berendsen R, Lammering G, Clarijs R, et al. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol. 2013;23(12):3440\u201349.","journal-title":"Eur Radiol"},{"key":"1016_CR15","doi-asserted-by":"crossref","unstructured":"Awiwi MO, Kaur H, Ernst R, Rauch GM, Morani AC, Stanietzky N, et al. Restaging MRI of rectal adenocarcinoma after neoadjuvant chemoradiotherapy. Imag Findings Potential Pitfalls Radiographics. 2023;43(4):e220135.","DOI":"10.1148\/rg.220135"},{"issue":"2","key":"1016_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1148\/radiol.212905","volume":"305","author":"QY Lu","year":"2022","unstructured":"Lu QY, Guan Z, Zhang XY, Li XT, Sun RJ, Li QY, et al. Contrast-enhanced MRI for T restaging of locally advanced rectal cancer following neoadjuvant chemotherapy and Radiation therapy. Radiology. 2022;305(2):364\u201372.","journal-title":"Radiology"},{"key":"1016_CR17","doi-asserted-by":"crossref","unstructured":"Miao G, Liu L, Liu J, Zeng M, Fowler K, Wolfe S. Arterial mucosal linear enhancement at contrast-enhanced MRI to exclude residual tumor after neoadjuvant chemotherapy and Radiation therapy for rectal cancer. Radiology. 2024;312(2):e232713.","DOI":"10.1148\/radiol.232713"},{"key":"1016_CR18","doi-asserted-by":"crossref","unstructured":"Liao CK, Kuo YT, Chern YJ, Hsu YJ, Lin YC, Yu YL, et al. Tegafur-Uracil\/Leucovorin Plus oxaliplatin (TEGAFOX) as Consolidation regimen after Short-course radiotherapy is effective for locally advanced rectal cancer. J Clin Med. 2022;11(10):2920.","DOI":"10.3390\/jcm11102920"},{"key":"1016_CR19","doi-asserted-by":"crossref","unstructured":"Jayaprakasam VS, Alvarez J, Omer DM, Gollub MJ, Smith JJ, Petkovska I. Watch-and-wait approach to rectal cancer: the role of imaging. Radiology. 2023;221529.","DOI":"10.1148\/radiol.221529"},{"issue":"6","key":"1016_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2214\/AJR.16.17242","volume":"209","author":"MA Lee","year":"2017","unstructured":"Lee MA, Cho SH, Seo AN, Kim HJ, Shin KM, Kim SH, et al. Modified 3-point MRI-Based tumor regression grade incorporating DWI for locally advanced rectal cancer. AJR Am J Roentgenol. 2017;209(6):1247\u201355.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"1016_CR21","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/01.STR.0000020355.29423.61","volume":"33","author":"K Yamada","year":"2002","unstructured":"Yamada K, Kubota H, Kizu O, Nakamura H, Ito H, Yuen S, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Stroke. 2002;33(7):1799\u2013802.","journal-title":"Stroke"},{"issue":"5","key":"1016_CR22","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.21037\/qims-23-1700","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Ao Y, Mu L, Wang C, Zhao J, Chen H, et al. Effect of contrast agent on T2-weighted fat-suppressed imaging and diffusion-weighted imaging in the diagnosis of breast tumors. Quant Imag Med Surg. 2024;14(5):3655\u201364.","journal-title":"Quant Imag Med Surg"},{"issue":"4","key":"1016_CR23","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00330-019-06565-2","volume":"30","author":"JK Jang","year":"2020","unstructured":"Jang JK, Choi SH, Park SH, Kim KW, Kim HJ, Lee JS, et al. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol. 2020;30(4):2312\u201323.","journal-title":"Eur Radiol"},{"issue":"11","key":"1016_CR24","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1007\/s00261-019-01894-8","volume":"44","author":"SC Nahas","year":"2019","unstructured":"Nahas SC, Nahas CSR, Cama GM, de Azambuja RL, Horvat N, Marques CFS, et al. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol (NY). 2019;44(11):3632\u201340.","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"1016_CR25","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/bjc.2017.320","volume":"117","author":"F Sclafani","year":"2017","unstructured":"Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes LST, Balyasnikova S, et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer. 2017;117(10):1478\u201385.","journal-title":"Br J Cancer"},{"issue":"9","key":"1016_CR26","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.crad.2016.05.005","volume":"71","author":"MR Siddiqui","year":"2016","unstructured":"Siddiqui MR, Gormly KL, Bhoday J, Balyansikova S, Battersby NJ, Chand M, et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol. 2016;71(9):854\u201362.","journal-title":"Clin Radiol"},{"issue":"1","key":"1016_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1148\/radiol.2532090027","volume":"253","author":"SH Kim","year":"2009","unstructured":"Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009;253(1):116\u201325.","journal-title":"Radiology"},{"key":"1016_CR28","doi-asserted-by":"crossref","unstructured":"Jang JK, C-M L, Park SH, Kim JH, Kim J, Lim S-B, et al. How to combine diffusion-weighted and T2-weighted imaging for MRI assessment of pathologic complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer? Korean J Radiol. 2021;22(9):1451\u221261.","DOI":"10.3348\/kjr.2020.1403"},{"issue":"6","key":"1016_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00384-016-2576-8","volume":"31","author":"LA Heijnen","year":"2016","unstructured":"Heijnen LA, Maas M, Beets-Tan RG, Berkhof M, Lambregts DM, Nelemans PJ, et al. Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging? Int J Colorectal Dis. 2016;31(6):1157\u201362.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"1016_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2521081364","volume":"252","author":"MJ Lahaye","year":"2009","unstructured":"Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bru\u00efne AP, Kwee HW, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology. 2009;252(1):81\u201391.","journal-title":"Radiology"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01016-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01016-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01016-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:52:21Z","timestamp":1776671541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01016-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01016-w","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the IRB of Chang Gung Memorial Hospital at Linkou (IRB No. 202400755B0) and conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived by the IRB due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}